NO970392D0 - Nye polymorfer av lesopitron-diklorhydrat og dets hydratiserte former, fremstillingsmetoder og sammensetning inneholdende dem - Google Patents

Nye polymorfer av lesopitron-diklorhydrat og dets hydratiserte former, fremstillingsmetoder og sammensetning inneholdende dem

Info

Publication number
NO970392D0
NO970392D0 NO970392A NO970392A NO970392D0 NO 970392 D0 NO970392 D0 NO 970392D0 NO 970392 A NO970392 A NO 970392A NO 970392 A NO970392 A NO 970392A NO 970392 D0 NO970392 D0 NO 970392D0
Authority
NO
Norway
Prior art keywords
lesopitron
dichlorohydrate
preparation
methods
composition containing
Prior art date
Application number
NO970392A
Other languages
English (en)
Other versions
NO970392L (no
NO310073B1 (no
Inventor
Pilar Lupon Roses
Jaime Tomas Navarro
Salvador Puig Torres
Jordi Frigola Constansa
Original Assignee
Esteve Labor Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Esteve Labor Dr filed Critical Esteve Labor Dr
Publication of NO970392D0 publication Critical patent/NO970392D0/no
Publication of NO970392L publication Critical patent/NO970392L/no
Publication of NO310073B1 publication Critical patent/NO310073B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO970392A 1995-05-31 1997-01-29 Nye polymorfer av lesopitron-diklorhydrat og dets hydratiserte former, fremstillingsmetoder og sammensetning inneholdende dem NO310073B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES09501086A ES2099031B1 (es) 1995-05-31 1995-05-31 Nuevos polimorfos de diclorhidrato de lesopitron y sus formas hidratadas, procedimientos de preparacion y composiciones que los contienen.
PCT/ES1996/000121 WO1996038439A1 (es) 1995-05-31 1996-05-29 Nuevos polimorfos de diclorhidrato de lesopitron y sus formas hidratadas, procedimientos de preparacion y composiciones que los contienen

Publications (3)

Publication Number Publication Date
NO970392D0 true NO970392D0 (no) 1997-01-29
NO970392L NO970392L (no) 1997-04-01
NO310073B1 NO310073B1 (no) 2001-05-14

Family

ID=8290585

Family Applications (1)

Application Number Title Priority Date Filing Date
NO970392A NO310073B1 (no) 1995-05-31 1997-01-29 Nye polymorfer av lesopitron-diklorhydrat og dets hydratiserte former, fremstillingsmetoder og sammensetning inneholdende dem

Country Status (29)

Country Link
US (1) US5872125A (no)
EP (1) EP0771798A1 (no)
JP (1) JPH10503532A (no)
CN (1) CN1076020C (no)
AR (1) AR003952A1 (no)
AU (1) AU699210B2 (no)
BG (1) BG62966B1 (no)
CA (1) CA2196425A1 (no)
CO (1) CO4700461A1 (no)
CZ (1) CZ24797A3 (no)
EE (1) EE9700067A (no)
ES (1) ES2099031B1 (no)
GE (1) GEP20002241B (no)
HU (1) HUP9700284A3 (no)
IL (1) IL118494A0 (no)
IN (1) IN186820B (no)
IS (1) IS4420A (no)
MA (1) MA23883A1 (no)
MX (1) MX9700792A (no)
NO (1) NO310073B1 (no)
NZ (1) NZ308110A (no)
PL (1) PL318280A1 (no)
RU (1) RU2178789C2 (no)
SK (1) SK12697A3 (no)
TR (1) TR199600455A2 (no)
UY (1) UY24241A1 (no)
WO (1) WO1996038439A1 (no)
YU (1) YU32396A (no)
ZA (1) ZA964139B (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6869970B2 (en) 2002-02-04 2005-03-22 Novartis Ag Crystalline salt forms of valsartan

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2642759B1 (fr) * 1989-02-09 1991-05-17 Laboratorios Esteve Sa Derives de pyrimidyl-piperazinyl-alkyl azoles avec activite anxiolytique et/ou tranquillisante
FR2654621B1 (fr) * 1989-11-22 1994-09-23 Esteve Labor Dr Inhibition du syndrome d'abstinence.
FR2672052B1 (fr) * 1991-01-28 1995-05-24 Esteve Labor Dr Derives d'aryl (ou heteroaryl)-piperazinyl-alkyl-azoles, leur preparation et leur application en tant que medicaments.
FR2671972B1 (fr) * 1991-01-25 1995-03-03 Esteve Labor Dr Utilisation de derives 1-h-azole-(omega-(4-(2-pyrimidinyl)-1-piperazinyl)-alkyl) pour la preparation de medicaments destines au traitement des troubles des fonctions cognitives.
FR2673628B1 (fr) * 1991-03-07 1993-07-09 Esteve Labor Dr Procede de preparation de derives d'aryl (ou heteroaryl)-piperazinyl-butyl-azoles.
FR2705098B1 (fr) * 1993-05-10 1995-08-04 Esteve Labor Dr Procédé de préparation de 2-{4-[4-(chloro-1-pyrazolyl)butyl]1-pipérazinyl}pyrimidine (Lesopitron) .

Also Published As

Publication number Publication date
HUP9700284A2 (en) 1997-11-28
CN1076020C (zh) 2001-12-12
US5872125A (en) 1999-02-16
JPH10503532A (ja) 1998-03-31
YU32396A (sh) 1999-07-28
NZ308110A (en) 1997-08-22
IS4420A (is) 1997-01-29
ZA964139B (en) 1997-02-06
PL318280A1 (en) 1997-06-09
ES2099031A1 (es) 1997-05-01
GEP20002241B (en) 2000-09-25
AU699210B2 (en) 1998-11-26
RU2178789C2 (ru) 2002-01-27
CA2196425A1 (en) 1996-12-05
EE9700067A (et) 1997-10-15
BG62966B1 (bg) 2000-12-29
CZ24797A3 (en) 1997-05-14
AU5765096A (en) 1996-12-18
IN186820B (no) 2001-11-17
WO1996038439A1 (es) 1996-12-05
SK12697A3 (en) 1997-07-09
NO970392L (no) 1997-04-01
MX9700792A (es) 1997-05-31
UY24241A1 (es) 1996-06-14
CN1158128A (zh) 1997-08-27
BG101176A (en) 1997-08-29
IL118494A0 (en) 1996-09-12
ES2099031B1 (es) 1997-12-01
HUP9700284A3 (en) 1998-01-28
TR199600455A2 (tr) 1996-12-21
NO310073B1 (no) 2001-05-14
AR003952A1 (es) 1998-09-30
CO4700461A1 (es) 1998-12-29
HU9700284D0 (en) 1997-04-28
EP0771798A1 (en) 1997-05-07
MA23883A1 (fr) 1996-12-31

Similar Documents

Publication Publication Date Title
NO973479L (no) Substituerte heterosykliske forbindelser, fremgangsmåte for fremstilling og farmasöytiske blandinger inneholdende samme
NO972214D0 (no) Fremgangsmåte for rensing og isolering av 2'-deoksy-2',2'-difluornukleosider
IS4536A (is) Ný taxóíð, aðferð til framleiðslu þeirra og lyfjasamsetningar sem innihalda þau
NO991732L (no) Nye heterocyklylmetylsubstituerte pyrazolderivater
IS4635A (is) 4-fenýlamínóþíasólafleiður, aðferð við að framleiða þær og lyfjablöndur sem innihalda þær
NO305833B1 (no) Naftylforbindelser, mellomprodukter og anvendelse av forbindelsene
NO961006L (no) Fosfonomononukleinsyrer, fremgangsmåter for fremstilling derav og anvendelse av forbindelsene
DK1398A (da) Antifungalt middel, forbindelse til dette, fremgangsmåde til fremstilling af denne og metode til dets anvendelse
PL323723A1 (en) Novel derivatives of dolastatin, their production and application
NO980715D0 (no) Antipruriginöse, kosmetiske og/eller farmasöytiske sammensetninger bestående av en eller flere lette lokale anestesimider og en eller flere astringente forbindelser
NO950861D0 (no) Katalysator og fremgangsmåte for syntesen av klordioksyd og fremgangsmåte for fremstilling av katalysator for syntesen av klordioksyd
PL324436A1 (en) Novel derivatives of oxazolydinone, method of obtaining them and therapeutic agents containing such compounds
NO985292D0 (no) FremgangsmÕte for fremstilling av 1,4-butandiol, <gamma>-butyrolacton, og tetrahydrofuran
DK0732328T3 (da) Heterocykliske, aromatiske forbindelser, farmaceutiske og kosmetiske sammensætninger, der indeholder dem, og anvendelser
NO970392D0 (no) Nye polymorfer av lesopitron-diklorhydrat og dets hydratiserte former, fremstillingsmetoder og sammensetning inneholdende dem
PL325632A1 (en) Derivatives of pyrizin-2-one, their application and intermediate compounds for obtaining them
NO961677D0 (no) Nye cykloheksanforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem
DK0806949T3 (da) Ny farmaceutisk komposition, der indeholder trimebutin, og fremgangsmåde til fremstilling deraf
IS4035A (is) Benzodiazepinesefni, aðferð til framleiðslu þeirra og notkunar sem lyfja
DK0853593T3 (da) Syntetisk, porøst, krystallinsk MCM-61, dets syntese og anvendelse
NO982105L (no) Nye mellomprodukter og deres anvendelse for fremstilling av N,N'-broslÕtte bisindolylmaleimider
NO971419L (no) Fremgangsmåte for fremstilling av 1,3-alkendioler og 3-hydroksyaldehyder
PL312209A1 (en) Novel compounds of seccomacrolydes and seccoazalydes class, intermediate compounds and method of obtaining them
HUP9700437A3 (en) Guanidino-derivatives of substituted thienyl-alkenyl-carboxylic-acids, their production, and pharmaceutical compositions containing them
PL329053A1 (en) Novel derivatives of oxazolydine, method of obtaining them and therapeutic agents containing such compounds

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN NOVEMBER 2002